Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

2020 Nature 2,086 citations

Keywords

VirologyMonoclonal antibodyAntibodyNeutralizationEpitopeCoronavirusGlycoproteinBiologyPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusImmunologyMedicineCoronavirus disease 2019 (COVID-19)DiseaseMolecular biologyInfectious disease (medical specialty)

MeSH Terms

Angiotensin-Converting Enzyme 2AnimalsAntibodiesMonoclonalAntibodiesNeutralizingAntibodiesViralAntibody-Dependent Cell CytotoxicityB-LymphocytesBetacoronavirusCOVID-19Chlorocebus aethiopsCoronavirus InfectionsCross ReactionsCryoelectron MicroscopyEpitopesB-LymphocyteHEK293 CellsHumansImmune EvasionImmunoglobulin Fab FragmentsImmunologic MemoryKiller CellsNaturalModelsMolecularNeutralization TestsPandemicsPeptidyl-Dipeptidase APneumoniaViralSevere acute respiratory syndrome-related coronavirusSARS-CoV-2Severe Acute Respiratory SyndromeSpike GlycoproteinCoronavirusVero Cells

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
583
Issue
7815
Pages
290-295
Citations
2086
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

2086
OpenAlex
132
Influential

Cite This

Dora Pinto, Young‐Jun Park, Martina Beltramello et al. (2020). Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature , 583 (7815) , 290-295. https://doi.org/10.1038/s41586-020-2349-y

Identifiers

DOI
10.1038/s41586-020-2349-y
PMID
32422645

Data Quality

Data completeness: 72%